Stem cells are highly abundant during early development but become a rare population in most adult organs. The molecular mechanisms causing stem cells to exit proliferation at a specific time are not well understood. Here, we show that changes in energy metabolism induced by the steroid hormone ecdysone and the Mediator initiate an irreversible cascade of events leading to cell-cycle exit in Drosophila neural stem cells. We show that the timely induction of oxidative phosphorylation and the mitochondrial respiratory chain are required in neuroblasts to uncouple the cell cycle from cell growth. This results in a progressive reduction in neuroblast cell size and ultimately in terminal differentiation. Brain tumor mutant neuroblasts fail to undergo this shrinkage process and continue to proliferate until adulthood. Our findings show that cell size control can be modified by systemic hormonal signaling and reveal a unique connection between metabolism and proliferation in stem cells.
INTRODUCTION
Stem cells exit proliferation at defined times during development. When organogenesis is completed, they enter senescence, differentiate, or die (Iglesias-Bartolome and Gutkind, 2011) so postnatal animals or adults contain much lower numbers of stem cells (Kalyani and Rao, 1998; Cai et al., 2002) . Persistence of embryonic stem cell populations into adulthood results in tumorigenesis (Blum and Benvenisty, 2008) and stem cells in tumors often regain embryonic properties (Janic et al., 2010) . Understanding how the timely disappearance of stem cell populations is coordinated with developmental timing is therefore important for both stem cell and tumor biology.
Drosophila neural stem cells are called neuroblasts (NBs) and provide a tractable system to study stem cell proliferation and terminal differentiation (Kohlmaier and Edgar, 2008; SousaNunes et al., 2010; Chang et al., 2012; Homem and Knoblich, 2012) . NBs divide asymmetrically into a larger cell that maintains stem cell identity and a smaller cell committed to differentiation. This is achieved through the differential segregation of the kinase aPKC into the larger daughter cell and the cell fate determinants Numb, Prospero, and Brat into the smaller daughter cell (Hirata et al., 1995; Knoblich et al., 1995; Rolls et al., 2003; Betschinger et al., 2006) . When the machinery for asymmetric cell division is perturbed, NBs accumulate leading to the formation of massive brain tumors that can be transplanted and become metastatic over time (Gateff, 1978; Gateff et al., 1993; Caussinus and Gonzalez, 2005; Betschinger et al., 2006; Lee et al., 2006; Wang et al., 2006) .
During larval stages, NBs divide hundreds of times to selfrenew and generate differentiated neurons or glia. After every division, each NB re-grows to its original size and therefore maintains a constant volume throughout larval development (Ito and Hotta, 1992; Homem et al., 2013) . During the pupal stages, NBs continue dividing for a limited time but disappear before adult stages (White and Kankel, 1978; Truman and Bate, 1988) leading to minimal or no proliferation in the adult Drosophila brain (von Trotha et al., 2009; Ferná ndez-Herná ndez et al., 2013) . As distinct NB subpopulations disappear at different times (Truman and Bate, 1988) , cell-cycle exit is not simply a response to a systemic program. Distinct mechanisms have been postulated for the timely disappearance of various subgroups of NBs. In the abdominal ventral nerve cord (VNC), NBs die by apoptosis (Bello et al., 2003) whereas a combination of apoptosis and autophagy eliminates the mushroom body NBs, a particularly long-lived subpopulation of NBs in the central brain (CB) (Siegrist et al., 2010) . In the majority of CB NBs, however, a terminal symmetric division preceded by a reduction in cell size terminates the proliferative state at a specific time during pupal development (Maurange et al., 2008) .
The mechanisms that trigger terminal symmetric division or apoptosis at a specific time are currently not understood. Like Drosophila embryonic NBs, larval NBs in the thoracic region of the VNC progress through distinct temporal stages expressing specific transcription factors in a temporally defined manner (Maurange et al., 2008; Chai et al., 2013) . How these temporal factors ultimately lead to stem cell exit is unclear.
Here, we show that a change in NB metabolism induced by the steroid hormone ecdysone and the Mediator complex at the larval to pupal transition leads to a reduction in cell growth and to uncoupling between cell size and cell-cycle progression that is responsible for terminal differentiation. Our study shows that the connection between cellular growth and cell-cycle progression can be under developmental control and reveals a connection between transcription regulation of metabolism and stem cell terminal differentiation. It further suggests a mechanism by which metabolism regulates cancer cell proliferation.
RESULTS

Cell-Autonomous Growth Reduction Precedes
Proliferation Exit in NBs CB NBs constitute the larger population of NBs in the Drosophila brain and are classified into 86 type I, four mushroom body (MB), and eight type II NBs. Type I and MB NBs divide to generate one NB and one ganglion mother cell (GMC) that divides once more to produce two neurons or glia cells. Type II NBs give rise to one NB and one intermediate neural progenitor (INP) that can self-renew a limited number of times generating one INP and one GMC. Both type I and type II NBs express the cortical marker Miranda (Mira) while only type I NBs also express the nuclear transcription factor Asense (Ase) (Bello et al., 2008; Bowman et al., 2008) .
Stem cell proliferation in the CB is ended by a symmetric terminal division of a smaller sized NB (Maurange et al., 2008) . To identify the events leading to this terminal division, we quantified cell size and growth rates at various times. Both type I and type II pupal NBs became smaller during pupal development ( Figures 1A-1C and Figure S1F available online). Plotting cell diameter versus the time after pupa formation (APF) revealed that the different types of NBs reduced their size at different rates. Type II NBs and posterior type I NBs started larger, but lost volume more rapidly, reaching the size of their daughter INPs or GMCs, respectively, at 16 hr APF (Figures 1C and S1F) , at which point NBs disappeared (Figures S1C-S1E). Anterior type I NBs, in contrast, started off smaller but shrank more slowly. They divided for a longer period and disappeared around 24 hr APF when they were as small as their daughter GMCs ( Figures 1C, S1A , S1B, S1E, and S1F). Volumetric calculations revealed that the rate of cell size reduction for each NB type corresponds to the volume lost to generate differentiated daughter cells (Figures S1G-S1I), indicating that a reduction in cell growth could lead to proliferation exit of CB Drosophila NBs.
The larva to pupa transition is accompanied by dramatic changes in tissue and organism growth (Cheng et al., 2011; Sousa-Nunes et al., 2011) , and altered nutrient supply could explain cell size reduction. To test the cell autonomy of NB shrinking and to quantify growth and cell-cycle length, we used a long-term culture system (Homem et al., 2013) . Like in vivo, both type I and type II larval and pupal NBs could divide multiple times in culture (Figures 1D and 1E ; Movies S1 and S2; data not shown). While larval NBs re-grew to their original size after each division ( Figures 1D and 1H ), pupal NBs cultured under the same conditions did not re-grow and therefore became progressively smaller ( Figures 1E and 1H ) until they underwent an equal size symmetric cell division ( Figure 1E , arrow heads in 22:24). Quantification of cell cycle and growth indicates that pupal NB size reduction is not due to an accelerated cell cycle; in fact during this stage NB cell cycle was slower ( Figure 1G ). Thus, a cell-autonomous modification of cell growth characteristics precedes proliferation exit in Drosophila NBs.
Defects in asymmetric cell division trigger brain tumor formation in flies. Tumorous NBs no longer exit the cell cycle and can persist into adulthood (Loop et al., 2004) . To test whether this is accompanied by a loss of cell size control, we cultured pupal NBs from flies expressing a transgenic brat RNAi construct (brat IR ). brat IR pupal NBs were still able to divide multiple times, but unlike wild-type (WT) pupal NBs, remained big and were indistinguishable from larval NBs (Figures 1F and 1H ; Movie S3). As the cell cycle duration of brat IR pupal NBs was not significantly different from pupal NBs ( Figure 1G ), we concluded that tumor NBs lose the ability to reduce growth in response to a developmental program. Taken together, these results suggest that a specific cellular program triggered during pupal stages causes Drosophila NBs to exit proliferation by inhibiting cellular growth in a cell-autonomous fashion.
NB Shrinkage Is Not Regulated by Common Cell Death or Growth Control Pathways
As the insulin/target of rapamycin (TOR) pathway (Greer and Brunet, 2005) has been shown to regulate lifespan in MB NBs (Siegrist et al., 2010) , we activated or inhibited insulin signaling and analyzed pupal brains at 24 hr APF when the majority of type I and all type II NBs have disappeared ( Figure S1E ). Activation of insulin signaling by overexpressing the insulin-like peptides (ILPs) ILP2 and ILP5 or a constitutively active insulin receptor InR (InRCA), or by RNAi of its effector FOXO did not prevent NB cell-cycle exit (Figures 2A-2E and S2A ). Conversely, inhibition of insulin signaling using dominant negative InR (InRDN), or FOXO overexpression also did not influence NB disappearance (Figures 2F, 2G, and S2A) .
PI3K is a convergence point of multiple growth signaling pathways (Cheng et al., 2011) . We therefore overexpressed PI3K ( Figure 2H ), its downstream effector AKT (Figures 2I and S2A) as well as the PI3K downstream effectors and TOR activators Ras homolog enriched in brain (Rheb) and S6K in pupal NBs ( Figures 2J, 2K , and S2A). Although activation of PI3K or AKT/TOR did not cause any observable phenotypes in larval stages, neither was sufficient to prevent pupal NB shrinkage and disappearance (Figures 2O, 2P, and S2A) . Together, these data show that the insulin/TOR and PI3K pathways are not sufficient to promote NB growth or prevent NB cell-cycle exit and disappearance.
Under starvation conditions, autophagy can be activated . Inhibition of this pathway with a dominant negative form of autophagy-specific gene 1 (UAS-ATG1 K38Q ) (Siegrist et al., 2010) caused no effect in CB NB size or number in late pupal stages (Figures 2L, 2O, 2P, and S2A) . Similarly, inhibition of apoptosis by overexpressing antiapoptotic p35 (Hay et al., 1994) was not capable of preventing pupal NB disappearance ( Figures 2M, 2O , 2P, and S2A).
Finally, decreasing reactive oxygen species by overexpressing superoxide dismutase 1 (SOD1) did not change pupal NB number or size ( Figures 2N-2P and S2A) . These results indicate Figure S1 and Movies S1, S2, and S3.
that there must be yet unknown mechanisms that regulate pupal NB growth and are responsible for their disappearance.
A Genome-wide RNAi Screen for NB Life Span and Growth As none of the known regulatory pathways explain NB shrinkage, we carried out a genome-wide in vivo RNAi screen for extended or reduced NB life span ( Figure 3A ). To streamline the protocol, we expressed a transgene encoding firefly luciferase together with RNAi lines from the Vienna Drosophila Research Center KK collection in CB type II NBs and their progeny. Although these transgenes are no longer expressed in adults, pilot experiments revealed considerable perdurance of luciferase activity into adulthood (data not shown). We used CB type II NBs because they are not essential for fly viability, allowing us to also probe the effect of genes essential for cell survival on luciferase expression. For each RNAi line, six heads from 1-day-old adults were homogenized in 96-well plates. Luciferase activity was measured in triplicates ( Figure 3B ) and signals were normalized to the average of the WT control. In total, we screened 9,700 RNAi lines each corresponding to a different gene (70% of the Drosophila protein coding genome). The vast majority of these caused either no change or a reduction in luciferase activity ( Figure 3C ). This is expected as NB cell death or mitotic arrest caused by RNAi of cell essential genes should decrease luciferase activity.
To identify genes inducing timely disappearance of NBs, we focused on a subset of 388 genes where at least one of the luciferase reads was more than 4-fold higher than the control and the variation coefficient for the three samples was below 0.4 (Table  S1 ). Gene Ontology (GO) term analysis of these 388 genes revealed that the category of stem cell differentiation was overrepresented ( Figure 3D , nodes with blue border, p = 0.002). This includes known tumor suppressor genes and NB temporal transcription factors. Their knock down results in adult NB proliferation (Bello et al., 2006; Maurange et al., 2008) nicely confirming our screening strategy. Analysis of protein-protein and genetic interactions between the identified genes revealed three distinct interaction clusters ( Figure 3D ). One cluster contained genes with no GO term enriched and was not pursued further (Figure 3D , gray outline, s = 2.5). A second cluster included five members of the Mediator complex ( Figure 3D , red outline, s = 1.8), while the third cluster contained three genes involved in oxidative phosphorylation (OxPhos) ( Figure 3D , green outline, s = 1). We focused on these genes for further analysis as they had not previously been connected to proliferation control in NBs.
The Mediator Complex Is Necessary to Induce Pupal NB Shrinkage Mediator is a highly conserved protein complex of 26-30 subunits that connects transcription factors to RNA Polymerase II (Malik and Roeder, 2010; Conaway and Conaway, 2013; Napoli et al., 2012) . Mediator maintains the pluripotent state of embryonic stem cells by binding so-called super enhancers and activating the transcriptional network for maintaining the ES cell state (Kagey et al., 2010; Whyte et al., 2013) .
As we identified multiple Mediator subunits in our screen (Figure 3D) , we analyzed the RNAi phenotype of the complex subunits in pupal NBs. To test if these genes are involved in NB disappearance, we performed this phenotypic analysis of NBs at 24 hr APF, a time point when most type I and all type II NBs have already disappeared in the WT. Transgenic RNAi constructs targeting eight Mediator subunits (Med4, Med6, Med9, Med10, Med11, Med22, Med27, Med31) prolonged lifetime and prevented shrinkage of both type I (Figures S3E-S3I and data not shown) and type II NBs (representative examples in quantified in Figures 4E and 4F) . RNAi of all these Mediator subunits did not have any obvious effect on larval NBs ( Figures S3A-S3D , S3L, and S3M). These RNAi phenotypes are specific as they could be confirmed by a secondary RNAi line ( Figure S3I ). In addition, NB lifespan could also be prolonged by expressing Med12 (Kohtalo, Kto), an inhibitory subunit that has been shown to repress Mediator function (Malik and Roeder, 2010) (Figures 4E, 4F , and 4K). To determine if these longer lived NBs continue proliferating we stained them for phosphohistone H3 (PH3), a marker of mitotic cells. In WT 24 hr pupal brains, we never detect PH3-positive NBs (0 of 15 brains scored). In Figures S4A and S4F ). To test whether prolongation of NB life-span produces excess neuronal progeny in vivo, we generated permanently labeled clones of med27 IR . We analyzed clones originating from posterior type I NBs, which normally disappear at 16 hr APF. Clones were generated during larval stages and analyzed 5 days later, at 24 hr APF or 28 hr APF. Indeed, NBs depleted of med27 generated significantly more neuronal progeny than WT (Figures 4L-4P) . Thus, the Mediator complex is required for timely reduction of cell size and for limiting proliferation in Drosophila NBs. However, Mediator is not a general inhibitor of cell growth. Expression of two independent med27 IR in wing imaginal discs led to small and abnormal wings ( Figures S3J and S3K) .
To 
Mediator Regulates Ecdysone Targets and Metabolic Enzymes in Pupal NBs
To identify the mechanism by which Mediator regulates NB proliferation, we determined its transcriptional targets. We isolated WT larval NBs, WT pupal NBs, and mediator RNAi pupal NBs by fluorescence-activated cell sorting (FACS) and determined transcript levels by RNA-sequencing ( Figure S4M ). Mediator function was inhibited by an RNAi line that reduces med27 mRNA levels by 90% (VDRC TID 106703) in NBs. To avoid indirect effects from cell size differences, we analyzed mRNA levels 0-2 hr APF when NBs are still present and are not yet strongly reduced in size ( Figure S4M ). This identified a set of 1,355 genes that were differentially regulated between WT larval and pupal NBs (fragments per kilobase of transcript per million fragments mapped [FPKM] >10, p < 0.01, log2-fold change >0.5; accession number GSE53265). Interestingly the majority of these (879 of 1,355 genes) were upregulated in pupal NBs, suggesting that pupal NBs might be transcriptionally more active ( Figure S4N ). In insects, the transition from larval to pupal stages is called metamorphosis and is triggered by a pulse of the steroid hormone ecdysone. Upon ligand binding, the ecdysone receptor (EcR) translocates into the nucleus where it first induces expression of a small group of early response genes, which mostly encode transcription factors. These early regulatory proteins then coordinate the expression of late response genes that ultimately induce morphological changes (Ou and King-Jones, 2013) . As expected, the genes differentially expressed between larval and pupal NBs were enriched for the GO categories metamorphosis/ecdysone signaling, neuronal differentiation and response to stimuli (Table S2) .
Interestingly, genes downregulated in pupal NBs were enriched for metabolism and energy production (Table S2) . To test if this difference in expression from larva to pupa is Mediator-dependent we next compared WT and med27 IR pupal NBs. We identified 732 genes that were significantly differentially expressed. GO term analysis of this set of genes revealed enrichment for both metamorphosis and metabolism.
Hierarchical clustering of our transcript data with a very stringent cutoff (FPKM >10 and fold change >2) revealed a group of genes that were highly upregulated in WT but not in med27 IR pupal NBs ( Figure 5A ). Among these are several ecdysone early induced genes (Eig) that are expressed at much lower levels in med27 IR pupal NBs ( Figure 5A , black line). These data were confirmed by qPCR: Eig were not expressed in larval NBs but were highly expressed in pupal NBs. Upon Mediator depletion with med27 RNAi or inhibition of ecdysone signaling with a dominant negative form of the EcR (EcRDN), Eig expression was severely reduced ( Figure 5B ). Thus, Med27 is required for EcR activity in NBs.
To test a more general requirement of Mediator for ecdysone signaling, we analyzed mushroom bodies, where ecdysone is known to specify the cell fate of late born a/b neurons (Kucherenko et al., 2012). As expected, EcR RNAi prevented proper differentiation of a/b neurons resulting in a smaller volume ( Figures  5C, 5D , and 5G) (Kucherenko et al., 2012) . Formation of the late born a/b neurons was completely prevented by EcRDN (Figure 5E ) indicating that the dominant negative receptor has a stronger effect than RNAi. As expression of med27 RNAi closely mimicked the phenotype of EcR RNAi and also prevented proper formation of a/b neurons ( Figures 5D and 5F ), we conclude that Mediator is required for EcR-induced morphological changes in mushroom bodies as well.
What could be the relationship between Mediator and ecdysone signaling? Mediator RNAi did not affect EcR transcription levels (accession number GSE53265) nor did it disrupt EcR subcellular localization in larval or pupal NBs (Figures S4O and  S4P ). Co-immunoprecipitation (coIP) experiments revealed that Mediator binds to the EcR ( Figure 5H ), indicating that Mediator does not affect EcR directly but is required for ecdysoneinduced transcription instead, possibly forming a complex with the active receptor on chromatin.
We therefore tested whether ecdysone signaling might be the temporal trigger that changes cell growth in NBs. As the VDRC KK collection does not contain an RNAi line targeting EcR and it was therefore not included in our screen, we used an independent EcR RNAi line and also EcRDN. When expressed in NBs, both EcRDN and EcR RNAi prevented pupal NB shrinkage in type I NBs (average diameter at 24 hr APF: WT = 5.2 mm, EcRDN = 10.4 mm) and type II NBs (Figures 5I-5K ). Pupal NB shrinkage is also prevented when ecdysone signaling is inhibited by expressing the EcR ligand binding domain (Kozlova and Thummel, 2002) , thereby sequestering ecdysone hormone (Figures S4Q and S4R) . Similar results were observed upon expression of a dominant negative version of Taiman (Tai-nls-LXXLL) (Jang et al., 2009 ), a histone-modifying enzyme required for EcR to regulate transcription (Bai et al., 2000) (Figure 5L ). Despite the defects, cultured pupal NBs expressing EcRDN were mitotically active and divided asymmetrically ( Figures 5M and 5N) . Inhibition of EcR in vivo effectively led to mitotically active ( Figures  S4B and S4F ) and longer-lived NBs, resulting in increased number of the neuronal progeny generated (Figures S4G, S4H , and S4L). Thus, ecdysone signaling is essential for NBs to transit from the proliferating to the shrinking stage and timely cell-cycle exit.
Mediator-Induced Metabolic Changes Are Required for NB Shrinkage Besides ecdysone signaling, our transcriptome analysis revealed a number of key metabolic enzymes downregulated in med27 IR pupal NBs. These include enzymes in major metabolic pathways, such as glycolysis, Krebs cycle, fatty acid metabolism, purine metabolism, pentose phosphate pathway, as well as alanine, aspartate, glutamate, glutathione, galactose, glycerolipid, and nitrogen metabolism (accession number GSE53265). Most of the enzymes that were deregulated in med27 IR NBs catalyze reversible reactions, which complicate their analysis. However, we also found several enzymes controlling the irreversible, rate-limiting steps of metabolic pathways. This set includes phosphofructokinase (Pfk) catalyst of a ratelimiting step of glycolysis; adenosine 3 (ade3), a predicted phosphoribosylglycinamide synthetase catalyzing an irreversible step in purine biosynthesis; CG5214, a predicted E2 member of the a-ketoglutarate dehydrogenase complex (a-KGDHC) that catalyzes a rate-limiting step in the Krebs cycle; and pyruvate carboxylase (PC, CG1516), a mitochondrial enzyme catalyzing the conversion of pyruvate to oxaloacetate for multiple metabolic pathways ( Figure 6A ). The levels of a-KGDHC, PC, and ade3 increased from larva to pupa and as expected this increase was abrogated in both med27 IR and EcRDN backgrounds ( Figure 6A ). Pfk was not found to be differentially expressed between larval and pupal NBs and thus was not pursued further ( Figure 6A ). To test if the differentially expressed enzymes are required for NB shrinkage we individually knocked down a-KGDHC, PC, and ade3. RNAi of PC and ade3 had no effect on pupal NBs ( Figure 6B ). a-KGDHC RNAi, in contrast, prevented NB shrinkage ( Figure 6B ) and prolonged NB life span in pupae ( Figures 6B-6E , S4D, S4F, S4J, and S4L) while it had no effect in larval NBs ( Figure S5B ). Thus, a-KGDHC seems to play a particularly important role in inducing NB shrinkage. a-KGDHC is a key regulatory enzyme complex in the Krebs cycle ( Figure 6F ) (Cooney et al., 1981) that generates NADH, the key substrate for the respiratory chain. Inhibition of a-KGDHC leads to a reduction in NADH levels (Tretter and Adam-Vizi, 2000 ; see also Figure 7C below) and, as a consequence, oxidative phosphorylation (OxPhos) (Tretter and Adam-Vizi, 2000; McLain et al., 2011) . It was therefore interesting that one of the clusters identified in our screen contained multiple components of OxPhos ( Figure 3D ). We thus tested the effect of reducing OxPhos on NB shrinkage. Complete or near-complete inhibition of OxPhos by rotenone caused a cell-cycle block in NBs and could therefore not be used. We therefore used RNAi lines targeting various components in the mitochondrial electron transport chain reasoning that RNAi would only partially inhibit OxPhos because these components are among the most highly expressed genes in NBs (Berger et al., 2012 ) (described below). Transgenic RNAi lines targeting ubiquinol-cytochrome c oxidoreductase 14 kDa (Ucrh, CG3560, KK line, and independent secondary short hairpin RNAi line), cytochrome c oxidase subunit Va (CoVa, CG14724), cytochrome c oxidase polypeptide VIIc (CoAVIIc, CG2249), and cytochrome c oxidase IV (CoxIV, CG10664) did not prevent proliferation when expressed in type II larval NBs ( Figures S5A-S5F ). In pupal NBs, however, RNAi of any of these OxPhos components increased cell size and extended life span ( Figures 6G-6K , S4C, S4F, S4I, S4L, and S5I). When kept in culture, pupal NBs with reduced expression of the OxPhos regulator Ucrh divided normally and generated the correct neuronal lineage but the shrinkage observed in WT pupal NBs was completely prevented ( Figure S5H ). Taken together, these results suggest that regulation of OxPhos is at the heart of the metabolic changes induced by Mediator that lead to cell-cycle exit in pupal NBs.
We also observed that RNAi of CG7834, an electron transfer flavoprotein beta subunit (ETF) prevented pupal NB shrinkage and increased pupal NB life-span ( Figures 6L, S4E , S4F, S4K, and S4L), while having no effect in larval stages ( Figure S5G ). ETFs link oxidation of fatty acids and amino acids to oxidative phosphorylation, and disruption of ETFs results in fat and protein accumulation (Frerman and Goodman, 1985) . The fact that both depletion of ETFs and OxPhos components prevent NB shrinkage and timely differentiation, suggests that OxPhos depletes metabolites for biosynthesis and thereby reduces growth and induces NB shrinkage in pupae.
Differences in Energy Metabolism between Larval and Pupal NBs
To measure Mediator-and ecdysone-dependent metabolic changes, we first quantified oxygen consumption rates (OCR) in larval and pupal Drosophila brains. To avoid indirect effects from cell size differences, we analyzed metabolite levels 0-2 hr APF when NBs are not yet strongly reduced in size. Our experiments revealed a highly significant increase in OCR from larval to pupal stages ( Figure 7A ). This increase became statistically nonsignificant when we depleted med27 by RNAi or ecdysone signaling with EcRDN in NBs ( Figure 7A ). Thus, Mediator and ecdysone induce a change in metabolic flux that contributes to the increase in OxPhos. As med27 IR or EcRDN were only expressed in NBs, we conclude that upregulation of OxPhos in NBs is largely responsible for the increase in OCR within the Drosophila brain. As reducing OxPhos prevented shrinkage of pupal NBs, we next tested the metabolic consequences of directly inhibiting the respiratory chain by RNAi of the complex III component Ucrh. RNAi of Ucrh in NBs reduced OCR rates as expected (Figure 7B) . At the same time, NADH levels were significantly increased ( Figure 7B) . Importantly, however, overall energy/ ATP levels were unchanged in Ucrh IR brains ( Figure 7B ). We conclude from the decrease in OCR and increase in NADH levels that the mitochondrial electron chain is partially blocked and that there is less aerobic respiration with a consequent accumulation of NADH. To test if these metabolic changes are an indirect consequence of changes in mitochondrial morphology, we stained mitochondria. Mitochondria showed a punctate pattern in larval and early pupal brains, including the stages when NB shrinkage occurs. After 8-10 hr APF, however, mitochondria became fused and displayed significant morphological alterations. As those changes occur both in NBs and the surrounding tissues, are unaffected by RNAi of Mediator, ecdysone, Uchr, or a-KGDHC, and occur long after the start of NB shrinkage ( Figure S6 ), we conclude that they are not responsible for the size reduction in NBs.
To get an estimate of the amount of anaerobic glycolysis occurring when OxPhos is inhibited, we measured lactate levels. In WT brains, lactate levels strongly decreased from larval to pupal stages. In Ucrh IR animals, however, lactate levels were reduced and unchanged between larval and pupal stages ( Figure 7B ). It is interesting to note that a reduction in OxPhos levels did not cause an increase in lactate as one would predict if glycolysis and OxPhos were in an isolated equilibrium. In reality, however, multiple biosynthetic and energy storage pathways feed from glycolytic intermediate metabolites, and accumulating metabolites will be redistributed in the metabolic network depending on the context of the cell (McKnight, 2010) . We next tested whether the metabolic profile of NBs depleted of Mediator or EcR is similar to the one resulting from OxPhos inhibition. Upon reducing Mediator or ecdysone activity, lactate levels were significantly lower in larvae and slightly higher in pupae, effectively reducing the difference between the two stages ( Figure 7C ). Consistent with the observed reduction in OCR in brains expressing EcRDN, we also observed a decrease in NADH levels. Overall, the effect of EcRDN was stronger than the one caused by med27 RNAi. We assume this is due to a stronger effect of EcRDN on the pathway, consistent with the stronger phenotypes observed in mushroom bodies ( Figures  5C-5E ). Direct reduction of NADH levels and consequently OxPhos by depleting NBs of a-KGDHC also attenuated the difference in lactate levels between larva and pupa ( Figure 7C ). In spite of the observed metabolic changes for all these genotypes, the overall energy/ATP level did not change ( Figure 7C ). Thus, although we have found a-KGDHC as a major target of Mediator and ecdysone, changes of this enzyme alone cannot explain the metabolic changes that we observe in pupal stages. The striking cellular phenotypes of a-KGDHC, med27, or EcR RNAi, however, suggest that those other metabolic changes are not sufficient for NB shrinkage.
Taken together, our data indicate that ecdysone-and Mediator-induced alterations of glucose and energy metabolism initiate a cascade of events that ultimately ends the proliferative phase in Drosophila neural stem cells ( Figure 7D ). 
DISCUSSION
Mediator-and Steroid Hormone-Induced Growth Reduction Precedes Terminal Differentiation
The mechanisms that couple cell-cycle progression to cell growth are still controversial (Lloyd, 2013) . It is thought that cellular growth rates are influenced by nutrient availability (Laporte et al., 2011) and extracellular growth factors. Our data indicate, however, that the major reduction of Drosophila NB growth at the larva to pupa transition is independent of the insulin pathway, the major sensor for extracellular nutrient supply. We show that ecdysone signaling is required for this change, suggesting that it is initiated by the larva-pupa pulse of ecdysone (Ou and King-Jones, 2013) . Once the switch has occurred, however, it is stably maintained as the differences in growth behavior are maintained in co-cultures of larval and pupal NBs even under identical ecdysone levels ( Figures 1D and 1E) .
Our results are consistent with previous observations showing that a series of transcriptional regulators confers temporal identity to NBs (Grosskortenhaus et al., 2005; Maurange et al., 2008) . Seven-up (Svp) is the last transcription factor in this series. It is expressed until early pupal stages and required for timely NB differentiation (Chai et al., 2013; Ou and King-Jones, 2013) . It is unlikely that ecdysone simply triggers the transition to another, not yet identified transcription factor in this series. First, our analysis did not identify a transcriptional regulator that is upregulated in pupal NBs and required for shrinkage (data not shown). Second, Svp expression is not lower in pupal compared to larval NBs (aAccession number GSE53265). More likely, therefore, ecdysone acts by modifying the Svp temporal state. Interestingly, Svp can compete for EcR binding with the EcR dimerization partner Ultraspiracles (Usp) and inhibit ecdysone-induced metamorphosis (Zelhof et al., 1995) , suggesting that the connection between steroid hormone signaling and the temporal cascade may in fact be very direct.
EcR has been shown to cooperate with multiple chromatin and transcriptional regulators (Badenhorst et al., 2005; Kirilly et al., 2011; Kugler et al., 2011) . Our data add the Mediator complex to this list. As mammalian Mediator interacts with estrogen receptor and is necessary for estrogen receptor-mediated transcription (Zhang et al., 2005) , it may play a general role in transmitting steroid hormone signals. Because only a subset of Mediator subunits are required for pupal NB regulation while RNAi of other subunits causes cell lethality (data not shown), it could be a specific subcomplex that performs the function in NBs. In vertebrates, specific Mediator subunits interact with individual transcription factors and affect gene expression controlled by these coregulators. Like its mammalian counterpart, Drosophila Mediator could have cell type/developmental stage-specific functions ( Figure S3 ) (Zhang et al., 2005; Jiang et al., 2010 ) that depend on its subunit composition.
In mammals, steroid hormone signaling is also involved in proliferation control. Prolonged presence of androgens and estrogens is implicated in the development of prostate and breast cancer, respectively (Pike et al., 1993; Culig and Santer, 2014) . In fact most of the established prostate and breast cancer treatments are designed to modulate steroid hormone production or response. The present study provides mechanistic connections between steroid hormone signaling, energy metabolism, and cell proliferation regulation that could impact on those treatments.
Upregulation of OxPhos Is Required for Stem Cell Terminal Differentiation
Our results show that Mediator induces changes in a large number of metabolic enzymes. It is therefore surprising that inhibition the E2 member of a-KGDHC alone can mimic the Mediator phenotype. a-KGDHC is a major redox sensor (McLain et al., 2011) and responsible for generating NADH, thus its inhibition is capable of preventing oxidative glucose metabolism. We propose that this results in the accumulation of metabolites, which can feed into biosynthetic pathways promoting NB growth and proliferation ( Figure S7 ). Consistent with this, OxPhos levels are increased in pupal brains and NB shrinkage is prevented by a reduction in OxPhos. In addition, we have found that depletion of ETF also prevents NB shrinkage and prolongs NB lifespan. ETF deficiency is the primary cause of Glutaric acidemia type II, a human metabolic disorder where reduced oxidation of lipids and amino acids leads to excess accumulation of fat and protein (Frerman and Goodman, 1985) . Prevention of catabolism with consequent accumulation of biomolecules could therefore also explain the reduced shrinkage we observe upon ETF RNAi in NBs.
Stem Cells and Metabolism
Unlike their differentiated counterparts, stem cells and induced pluripotent stem cells (iPS) (Simsek et al., 2010) rely heavily on anaerobic glycolysis instead of aerobic respiration. The switch from mitochondrial oxidative metabolism to glycolysis is also observed in most proliferative cells and our data indicate that this may be the cause and not just a consequence of differentiation. Interestingly, cancer cells primarily depend on glycolysis (Warburg, 1956 ) metabolizing glucose to lactic acid even in the presence of oxygen, a phenomenon commonly known as the Warburg effect. It is believed that reduced OxPhos promotes metabolic flux from intermediates of glycolysis into biosynthetic branches, allowing cell proliferation. Again, our data could indicate that this is causative for neoplastic development rather than a result of malignant transformation.
Because mammalian Mediator has been implicated as a regulator of both steroid hormone signaling (Jiang et al., 2010) and stem cell fate (Kagey et al., 2010; Whyte et al., 2013) we propose that the role of Mediator as a metabolic regulator in stem cells is conserved in mammalian systems. It will be interesting to test if defects in uncoupling stem cell cycle from growth contribute to neoplastic transformation of these cells.
EXPERIMENTAL PROCEDURES
Fly Strains and Immunohistochemistry w 1118 was used as WT for all immunofluorescence experiments. RNAi lines were obtained from the Vienna Drosophila RNAi center, and TriP lines were obtained from the Bloomington Stock Center. UAS-GFP-Med27 and the short hairpin RNA line for CG3560 were generated in this study. Fly crosses were set up and grown at 29 C to increase UAS/Gal4 expression and fluorescence intensity. Fixation and staining of larval brains were performed as previously described (Betschinger et al., 2006) . Pupae were collected as white pupae and aged for the desired number of hours at 29 C. Adobe Photoshop 7.0 was used to adjust input levels to span entire output grayscale and to adjust brightness and contrast. See also Extended Experimental Procedures.
Cell Dissociation, Primary Cell Cultures, and Live Imaging Third instar larvae or white pupae were dissected, enzymatically and mechanically dissociated and immediately plated in 0.01% poly-L-lysin-hydrobromide-coated glass bottom cell culture dishes and allowed to settle for 1 hr at room temperature. Before imaging, 1 ml of primary cell-culture Schneider's medium (Homem et al., 2013) was added to each chamber and imaging was performed immediately. See also Extended Experimental Procedures.
RNA Sequencing
RNAi line for med27 (TID106703) or the WT control TID60100 (empty Landing site VIE-260B) were crossed to UAS-dicer2;insc-Gal4 UAS-CD8::GFP (type I and type II NB driver). Brains from third instar larvae or white pupa were dissected and dissociated as for live imaging. Dissociated brains were sorted by FACS (FACS Aria III, BD) (Berger et al., 2012) , and NBs were directly collected into TRIzol (Invitrogen). mRNA and cDNA were prepared as described in Harzer et al. (2013) . Sample sequencing was performed on Hiseq2000. See also Extended Experimental Procedures.
Metabolic Assays UAS-RNAi lines, UAS-EcRDN or w 1118 were crossed to UAS-dicer2;inscGal4 UAS-CD8::GFP. The same number of adult flies was used to ensure equal diet. Because isolation of enough number of living NBs by FACS sorting was technically not possible, we performed these metabolic analyses with entire brains. Green third instar larvae or pupae 0-2 hr APF were selected and their brains dissected, collected in the appropriate lysis buffer in dry ice, and prepared according to kit instructions. Respiration rates were measured in real-time using a Seahorse XF-24 analyzer (Seahorse Bioscience). Each experiment was done with three to five technical replicas and performed independently at least three times. For inter-experiment comparison, all measurements were internally normalized versus internal WT larva. Statistical significance was evaluated by t test. See also Extended Experimental Procedures.
Co-IP and Western Blots
For coIP, larval brains expressing UAS-GFP-Med27 under the control of inscGal4 were used. tub-GFP was used as control. Thirty third instar larval brains of each genotype were dissected and collected in ice cold Rinaldini solution. Protein samples were prepared by grinding brains in low salt buffer (Tris-HCl 50 mM, NaCl 100 mM, MgCl 2 10 mM, EDTA 1 mM, 10% glycerol, 0.5% NP-40, protease inhibitors) with a plastic pestle. Immunoprecipitate was done with GFP-Trap beads (Chromotek). Immunoblots were blocked with dry milk and primary antibodies anti-EcR (DDA2.7, DSHB) and anti-GFP (Jl8-Clontech) were used at a dilution of 1:500 and 1:1,000, respectively. Signal was detected by ECL (Amersham).
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